These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27927773)

  • 1. Hematopoietic stem cell apheresis in the context of a related allogeneic transplant for acute myeloid leukemia: an unexpected outcome, medical emergency and ethical issue.
    Bourgeois M; Sonet A; Botson F; Graux C; Fabry A; André M; Deneys V
    Haematologica; 2017 Mar; 102(3):e115-e116. PubMed ID: 27927773
    [No Abstract]   [Full Text] [Related]  

  • 2. Biosimilar Filgrastim (Tevagrastim, XMO2) for Allogeneic Hematopoietic Stem Cell Mobilization and Transplantation in Patients with Acute Myelogenous Leukemia/Myelodysplastic Syndromes.
    Danylesko I; Sareli R; Bloom-Varda N; Yerushalmi R; Shem-Tov N; Shimoni A; Nagler A
    Biol Blood Marrow Transplant; 2016 Feb; 22(2):277-283. PubMed ID: 26343949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Allogeneic hematopoietic stem cell transplantations].
    Michallet M
    Transfus Clin Biol; 2011 Apr; 18(2):235-45. PubMed ID: 21466967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innovative two-step negative selection of granulocyte colony-stimulating factor-mobilized circulating progenitor cells: adequacy for autologous and allogeneic transplantation.
    Rambaldi A; Borleri G; Dotti G; Bellavita P; Amaru R; Biondi A; Barbui T
    Blood; 1998 Mar; 91(6):2189-96. PubMed ID: 9490708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mobilization of hematopoietic progenitors from normal donors using the combination of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor results in fewer plasmacytoid dendritic cells in the graft and enhanced donor T cell engraftment with Th1 polarization: results from a randomized clinical trial.
    Lonial S; Akhtari M; Kaufman J; Torre C; Lechowicz MJ; Flowers C; Sinha R; Khoury HJ; Langston AA; Waller EK
    Biol Blood Marrow Transplant; 2013 Mar; 19(3):460-7. PubMed ID: 23201472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-unit cord blood transplantation after granulocyte colony-stimulating factor-combined myeloablative conditioning for myeloid malignancies not in remission.
    Konuma T; Kato S; Ooi J; Oiwa-Monna M; Ebihara Y; Mochizuki S; Yuji K; Ohno N; Kawamata T; Jo N; Yokoyama K; Uchimaru K; Asano S; Tojo A; Takahashi S
    Biol Blood Marrow Transplant; 2014 Mar; 20(3):396-401. PubMed ID: 24333750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Volunteer unrelated donor experience after administration of filgrastim and apheresis for the collection of haemopoietic stem cells: the Australian perspective.
    Gordon SV; Nivison-Smith I; Szer J; Chapman JR
    Intern Med J; 2013 Nov; 43(11):1183-90. PubMed ID: 24007325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia.
    Fan Q; Liu H; Liang X; Yang T; Fan Z; Huang F; Ling Y; Liao X; Xuan L; Xu N; Xu X; Ye J; Liu Q
    J Hematol Oncol; 2017 Jul; 10(1):135. PubMed ID: 28676100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of number of apheresis procedures necessary in healthy donors to attain minimally required peripheral blood CD34+ cells.
    Namba N; Matsuo K; Kubonishi S; Kikuchi T; Maeda Y; Niiya M; Shinagawa K; Koide N; Ikeda K; Tanimoto M
    Transfusion; 2009 Nov; 49(11):2384-9. PubMed ID: 19624602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-to-Event Ratio to Predict Outcome in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation?
    Ustun C; DeFor TE; Rashidi A; Devine S; Miller J; Weisdorf D
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1804-1808. PubMed ID: 28688918
    [No Abstract]   [Full Text] [Related]  

  • 11. Addressing Ethical and Procedural Principles for Unrelated Allogeneic Hematopoietic Progenitor Cell Donation in a Changing Medical Environment.
    van Walraven SM; Egeland T; Borrill V; Nicoloso-de Faveri G; Rall G; Szer J;
    Biol Blood Marrow Transplant; 2018 May; 24(5):887-894. PubMed ID: 29410372
    [No Abstract]   [Full Text] [Related]  

  • 12. Mobilization of allogeneic peripheral blood stem cell donors with intravenous plerixafor mobilizes a unique graft.
    Schroeder MA; Rettig MP; Lopez S; Christ S; Fiala M; Eades W; Mir FA; Shao J; McFarland K; Trinkaus K; Shannon W; Deych E; Yu J; Vij R; Stockerl-Goldstein K; Cashen AF; Uy GL; Abboud CN; Westervelt P; DiPersio JF
    Blood; 2017 May; 129(19):2680-2692. PubMed ID: 28292947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential reduced-intensity chemotherapy for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia with rare cytogenetic abnormalities transformed from Fanconi anemia.
    Inoue A; Mori A; Yamazaki S; Suzuki R; Takitani K; Tamai H
    Pediatr Int; 2018 Sep; 60(9):893-894. PubMed ID: 30255979
    [No Abstract]   [Full Text] [Related]  

  • 14. Haploidentical
    Brissot E; Labopin M; Ehninger G; Stelljes M; Brecht A; Ganser A; Tischer J; Kröger N; Afanasyev B; Finke J; Elmaagacli A; Einsele H; Mohty M; Nagler A
    Haematologica; 2019 Mar; 104(3):524-532. PubMed ID: 30361416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes of granulocyte colony-stimulating factor-combined conditioning in allogeneic hematopoietic stem cell transplantation from HLA-identical family donors for myeloid malignancies.
    Konuma T; Kato S; Ishii H; Oiwa-Monna M; Asano S; Tojo A; Takahashi S
    Leuk Res; 2015 Jun; 39(6):625-31. PubMed ID: 25888304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of matched sibling donors versus unrelated donors in allogeneic stem cell transplantation for primary refractory acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT.
    Brissot E; Labopin M; Stelljes M; Ehninger G; Schwerdtfeger R; Finke J; Kolb HJ; Ganser A; Schäfer-Eckart K; Zander AR; Bunjes D; Mielke S; Bethge WA; Milpied N; Kalhs P; Blau IW; Kröger N; Vitek A; Gramatzki M; Holler E; Schmid C; Esteve J; Mohty M; Nagler A
    J Hematol Oncol; 2017 Jun; 10(1):130. PubMed ID: 28646908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral Blood Stem Cell Mobilization in Healthy Donors by Granulocyte Colony-Stimulating Factor Causes Preferential Mobilization of Lymphocyte Subsets.
    Melve GK; Ersvaer E; Eide GE; Kristoffersen EK; Bruserud Ø
    Front Immunol; 2018; 9():845. PubMed ID: 29770133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes and graft characteristics in pediatric hematopoietic stem cell transplantation: Effect of granulocyte-colony stimulating factor priming.
    Fettah A; Özbek N; Azık F; Tavil B; Özgüner M; Avcı Z; Işık P; Yaralı N; Uçkan D; Tunç B
    Transfus Apher Sci; 2015 Jun; 52(3):332-8. PubMed ID: 25779226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia: similar outcomes regardless of donor type.
    Warlick ED; Peffault de Latour R; Shanley R; Robin M; Bejanyan N; Xhaard A; Brunstein C; Sicre de Fontbrune F; Ustun C; Weisdorf DJ; Socie G
    Biol Blood Marrow Transplant; 2015 Feb; 21(2):357-63. PubMed ID: 25452032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.